Ipsen ships 18 furnaces in Q2, including 210,000-pound capacity vacuum furnace | ASM International
LeaveRussia: Ipsen is Pausing New Investments in Russia
Merrimack Provides Ipsen Report That Onivyde® Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Ipsen media library
Ipsen: a dynamic, fast-growing specialty care powerhouse
Ipsen (@IpsenGroup) / X
Press Releases / Melissa Peebles
Gebrüder Weiss takes over Ipsen Logistics' Air & Sea business | DC Velocity
Global Biopharmaceutical Company, Ipsen Announces New Headquarters for North America will be located in Cambridge, Massachusetts | Financial Post
Press Releases - Ipsen UK
Ipsen and Medetia join forces to accelerate early research in rare disease - Global
Ipsen: Patients Living with Spasticity Want Long-lasting Symptom Relief | Business Wire
Emirates Oncology Society And Ipsen Break Guinness World Record For Largest Awareness Ribbon | Press Release Network
Ipsen's quick fix backfires | Evaluate
Press releases
Mayoly Spindler completed the acquisition of Ipsen's CHC branch - MAYOLY SPINDLER laboratoire indépendant français
Ipsen CEO steers clear of gene therapy despite rare disease push
Press Releases - Ipsen UK
Pharma News and Updates | Ipsen, BioMarin, AbbVie, BMS, GSK, Novartis
Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership
Ipsen CEO David Loew is elected to EFPIA leadership; joins industry partners to warn of impact of EU pharma legislation - Global
Ipsen Adds Another Program Into Its Pre-Clinical R&D Oncology Pipeline Through an Exclusive Worldwide Collaboration With Accent Therapeutics, Targeting the RNA Modifying Protein, METTL3 | Business Wire
Ipsen Goes All In on Neuro with $1 Billion+ Deal For Exicure's Oligonucleotides | BioSpace
